A randomized, placebo-controlled trial of long-acting dexamethasone viscous gel delivered by transforaminal injection for lumbosacral radicular pain

Author:

Miller Alan1,Candido Kenneth D.2,Knezevic Nebojsa Nick2,Rivera José3,Lunseth Paul4,Levinson Dennis J.5,Formoso Ferdinand6,Solanki Daneshvari7,Tavel Edward8,Krull Angela9,Radnovich Richard10,Burkhead Daniel11,Souza Dmitri12,Helm Standiford13,Katz Nathaniel14,Dworkin Robert H.15,Cohen Steven P.16,Rathmell James P.17,Buvanendran Asokumar18,Levin Joshua19,Stannard Elizabeth20,Ambrose Chris21,Jaros Mark22,Vought Kip20,Lissin Dmitri21

Affiliation:

1. Coastal Clinical Research Specialists, Fernandina Beach, FL, United States

2. Chicago Anesthesia Pain Specialists, Chicago, IL, United States

3. Tampa Pain Relief Center, Tampa, FL, United States

4. Clinical Research of West Florida, Inc, Tampa, FL, United States

5. Chicago Clinical Research Institute, Inc, Chicago, IL, United States

6. Coastal Clinical Research Specialists, Jacksonville, FL, United States

7. Hermann Drive Research Hospital, Bellaire, TX, United States

8. Clinical Trials of South Carolina, Charleston, SC, United States

9. Physicians' Research Options, LLC, Draper, UT, United States

10. Injury Care Research, Boise, ID, United States

11. Innovative Pain Care Center, Las Vegas, NV, United States

12. Western Reserve Hospital, Cuyahoga Falls, OH, United States

13. The Helm Center for Pain Management, Laguna Hills, CA, United States

14. WCG Analgesic Solutions, Wayland, MA, United States

15. Department of Anesthesiology and Perioperative Medicine, Research, University of Rochester School of Medicine and Dentistry, Rochester, NY, United States,

16. Department of Anesthesiology and Critical Care Medicine, Johns Hopkins University, Baltimore, MD, United States

17. Department of Anethesiology, Perioperative and Pain Medicine, Harvard Medical School, Brigham and Women's Hospital, Boston, MA, United States

18. Department of Anesthesiology, Rush University, Chicago, IL, United States

19. Departments of Orthopedic Surgery and Neurosurgery, Stanford University, Stanford, CA, United States

20. Clinical Development and Medical Affairs, Consultants to Scilex Holding Company, Palo Alto, CA, United States

21. Clinical Development, Scilex Holding Company, Palo Alto, CA, United States

22. Summit Analytical LLC, Denver, CO, United States

Abstract

Abstract Epidural steroid injections are used to treat lumbosacral radicular pain. However, there are no Food and Drug Administration–approved corticosteroids for lumbosacral radicular pain and all currently available injectable corticosteroids carry safety warnings about their use in epidural steroid injection procedures. SP-102 (dexamethasone injectable viscous gel) was developed to provide a safer option with extended local effect. In a randomized, double-blind, placebo-controlled, multicenter trial, 401 patients with moderate-to-severe leg pain from unilateral intervertebral lumbar disc herniation were randomized (1:1) to receive transforaminal SP-102 or sham intramuscular (IM) placebo injection and followed for 24 weeks. If clinically warranted, a repeat open-label SP-102 injection was allowed between 4 and 20 weeks for both groups. Primary and key secondary end points were change in average daily pain on the Numeric Pain Rating Scale in the affected leg and disability measured by Oswestry Disability Index over 4 weeks. Other secondary end points included time to repeat injection, pain, and quality of life assessments. Over 4 weeks, SP-102 demonstrated statistically significant pain relief compared with placebo (least-squares mean group difference −0.52 [SE 0.163] [P = 0.002]) in the intent-to-treat population. Oswestry Disability Index mean improvement was −3.38 (1.388) (least-squares mean group difference [SE]) for SP-102 vs placebo (P = 0.015). Median time to repeat injection was 84 days for SP-102 vs 58 days for placebo (P = 0.001). Most other secondary end points were statistically significant for SP-102 compared with placebo. There were no serious adverse events related to study medication or procedure, no adverse events leading to death, and no AEs of special interest (paraplegia, hematoma, or infection). Trial Registration ClinicalTrials.gov Identifier: NCT03372161.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Reference39 articles.

Cited by 1 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3